CDE Detailed Report
Subdomain Name: Laboratory Tests and Biospecimens/Biomarkers
CRF: welcome
Displaying 1 - 16 of 16
CDE ID | CDE Name | Variable Name | Definition | Short Description | Question Text | Permissible Values | Description | Data Type | Disease Specific Instructions | Disease Specific Reference | Population | Classification (e.g., Core) | Version Number | Version Date | CRF Name (CRF Module / Guidance) | Subdomain Name | Domain Name | Size | Input Restrictions | Min Value | Max Value | Measurement Type | External Id Loinc | External Id Snomed | External Id caDSR | External Id CDISC |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C01711 | Lab test result unit of measure | LabTestResltUoM | Unit of measure for the laboratory test result | Unit of measure for the laboratory test result | Anti-pancreatic autoantibodies value | Alphanumeric |
No instructions available |
Vehik K, Beam CA, Mahon JL, Schatz DA, Haller MJ, Sosenko JM, Skyler JS, Krischer JP; TrialNet Natural History Study Group. Development of autoantibodies in the TrialNet Natural History Study. Diabetes Care. 2011 Sep;34(9):1897-901.<br /><br />Ziegler AG, Rewers M, Simell O, Simell T, Lempainen J, Steck A, Winkler C, Ilonen J, Veijola R, Knip M, Bonifacio E, Eisenbarth GS. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA. 2013 Jun 19;309(23):2473-9. | Adult;Pediatric | Supplemental-Highly Recommended | 3.00 | 2013-07-25 08:54:08.2 | Diabetes Labs | Laboratory Tests and Biospecimens/Biomarkers | Assessments and Examinations | 255 |
Free-Form Entry |
2787947 | ||||||||
C57974 | Laboratory procedure random glucose measurement | LabProcedRandomGlucoseMeasr | Measurement of the amount of glucose in the participant's blood at a random/non-fasting time | Measurement of the amount of glucose in the participant's blood at a random/non-fasting time | Random glucose value | Numeric Values |
Consider if unable to obtain fasting labs |
No references available | Adult;Pediatric | Supplemental | 2.00 | 2024-02-29 15:53:41.0 | Diabetes Labs | Laboratory Tests and Biospecimens/Biomarkers | Assessments and Examinations |
Free-Form Entry |
milligram per deciliter | |||||||||
C60249 | Laboratory procedure anti-pancreatic autoantibody name | LabProcedAntPncrticAtntbdyName | Name of the anti-pancreatic autoantibody measured in the participant's blood | Name of the anti-pancreatic autoantibody measured in the participant's blood | Anti-pancreatic autoantibodies | Alphanumeric |
Test for available diabetes-related autoimmunity (may include GAD 65, IA2, insulin, ZnT8).This CDE is Supplemental - Highly Recommended for individuals with diagnosed Diabetes Mellitus. |
Vehik K, Beam CA, Mahon JL, Schatz DA, Haller MJ, Sosenko JM, Skyler JS, Krischer JP; TrialNet Natural History Study Group. Development of autoantibodies in the TrialNet Natural History Study. Diabetes Care. 2011 Sep;34(9):1897-901.<br /><br />Ziegler AG, Rewers M, Simell O, Simell T, Lempainen J, Steck A, Winkler C, Ilonen J, Veijola R, Knip M, Bonifacio E, Eisenbarth GS. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA. 2013 Jun 19;309(23):2473-9. | Adult;Pediatric | Supplemental-Highly Recommended | 1.00 | 2024-02-29 15:53:38.0 | Diabetes Labs | Laboratory Tests and Biospecimens/Biomarkers | Assessments and Examinations | 255 |
Free-Form Entry |
|||||||||
C19730 | Laboratory procedure microalbumin urine measurement | LabProcedMicroalbuminUrinMeasr | Measurement of the amount of microalbumin in the participant's urine | Measurement of the amount of microalbumin in the participant's urine | Microalbumin, urine value | Numeric Values |
Measured in mg/dL (U.S.) or mmol/L (outside U.S.) (spot urine microalbumin/creatinine ratio) |
Adult;Pediatric | Supplemental | 2.00 | 2024-02-29 15:53:46.0 | Diabetes Labs | Laboratory Tests and Biospecimens/Biomarkers | Assessments and Examinations |
Free-Form Entry |
milligram per deciliter | ||||||||||
C18168 | Laboratory procedure total cholesterol measurement | LabProcedTotalCholesterolMeasr | Measurement of the total amount of cholesterol in the participant's blood | Measurement of the total amount of cholesterol in the participant's blood | Cholesterol, total value | Numeric Values |
Measured in mg/dL (U.S.) or mmol/L (outside U.S.) |
Adult;Pediatric | Supplemental | 4.00 | 2024-02-29 15:53:43.0 | Diabetes Labs | Laboratory Tests and Biospecimens/Biomarkers | Assessments and Examinations |
Free-Form Entry |
milligrams per deciliter | ||||||||||
C18169 | Laboratory procedure triglycerides measurement | LabProcedTriglyceridesMeasr | Measurement of the amount of triglycerides in the participant's blood | Measurement of the amount of triglycerides in the participant's blood | Triglycerides value | Numeric Values |
Measured in mg/dL (U.S.) or mmol/L (outside U.S.) |
Adult;Pediatric | Supplemental | 4.00 | 2024-02-29 15:53:45.0 | Diabetes Labs | Laboratory Tests and Biospecimens/Biomarkers | Assessments and Examinations |
Free-Form Entry |
milligrams per deciliter | ||||||||||
C19722 | Laboratory procedure glycosylated hemoglobin measurement | LabProcedGlycsyltdHbMeasr | Measurement of the amount of glycosylated hemoglobin (hemoglobin A1C) in the participant's blood | Measurement of the amount of glycosylated hemoglobin (hemoglobin A1C) in the participant's blood | Glycosylated Hemoglobin (Hemoglobin A1C) value | Numeric Values |
%, performed using a method certified by the National Glycohemoglobin Standardization Program (NGSP) and standardizable to the Diabetes Control and Complications Trial (DCCT) reference. |
American Diabetes Association. Standards of medical care in diabetes--2014. Diabetes Care. 2014 Jan;37 Suppl 1:S14-80. | Adult;Pediatric | Supplemental-Highly Recommended | 2.00 | 2024-02-29 15:41:24.0 | Diabetes Labs | Laboratory Tests and Biospecimens/Biomarkers | Assessments and Examinations |
Free-Form Entry |
percent | |||||||||
C19723 | Laboratory procedure anti-pancreatic autoantibodies value | LabPrcdAntiPancrAutoAntiVal | Value of the amount of anti-pancreatic autoantibodies in the participant's blood | Value of the amount of anti-pancreatic autoantibodies in the participant's blood | Anti-pancreatic autoantibodies value | Numeric Values |
Test for available diabetes-related autoimmunity (may include GAD 65, IA2, insulin, ZnT8). This CDE is Supplemental - Highly Recommended for individuals with diagnosed Diabetes Mellitus. |
Vehik K, Beam CA, Mahon JL, Schatz DA, Haller MJ, Sosenko JM, Skyler JS, Krischer JP; TrialNet Natural History Study Group. Development of autoantibodies in the TrialNet Natural History Study. Diabetes Care. 2011 Sep;34(9):1897-901.<br /><br />Ziegler AG, Rewers M, Simell O, Simell T, Lempainen J, Steck A, Winkler C, Ilonen J, Veijola R, Knip M, Bonifacio E, Eisenbarth GS. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA. 2013 Jun 19;309(23):2473-9. | Adult;Pediatric | Supplemental-Highly Recommended | 1.10 | 2024-02-29 15:53:36.0 | Diabetes Labs | Laboratory Tests and Biospecimens/Biomarkers | Assessments and Examinations |
Free-Form Entry |
||||||||||
C19724 | Laboratory procedure fasting glucose measurement | LabProcedFastingGlucoseMeasr | Measurement of the amount of glucose in the participant's blood when fasting | Measurement of the amount of glucose in the participant's blood when fasting | Fasting glucose value | Numeric Values |
Measured in mg/dL (U.S.) or mmol/L (outside U.S.) |
Adult;Pediatric | Supplemental-Highly Recommended | 2.00 | 2024-02-29 15:53:38.0 | Diabetes Labs | Laboratory Tests and Biospecimens/Biomarkers | Assessments and Examinations |
Free-Form Entry |
milligram per deciliter | ||||||||||
C19725 | Laboratory procedure two hour glucose measurement | LabProcedTwoHourGlucoseMeasr | Measurement of the amount of glucose in the participant's blood 2 hours after a 75-gram glucose drink has been ingested | Measurement of the amount of glucose in the participant's blood 2 hours after a 75-gram glucose drink has been ingested | 2-hour glucose (OGTT) value | Numeric Values |
Measured in mg/dL (U.S.) or mmol/L (outside U.S.) |
Adult;Pediatric | Supplemental | 2.00 | 2024-02-29 15:53:39.0 | Diabetes Labs | Laboratory Tests and Biospecimens/Biomarkers | Assessments and Examinations |
Free-Form Entry |
milligram per deciliter | ||||||||||
C19726 | Laboratory procedure fasting insulin measurement | LabProcedFastingInsulinMeasr | Measurement of the amount of insulin in the participant's blood when fasting | Measurement of the amount of insulin in the participant's blood when fasting | Fasting insulin value | Numeric Values |
Measured in mIU/L (U.S.) or pmol/L (outside U.S.) |
Adult;Pediatric | Supplemental | 2.00 | 2024-02-29 15:53:39.0 | Diabetes Labs | Laboratory Tests and Biospecimens/Biomarkers | Assessments and Examinations |
Free-Form Entry |
milli international units per liter | ||||||||||
C19727 | Laboratory procedure fasting C-peptide measurement | LabProcedFastingCPeptideMeasr | Measurement of the amount of C-peptide in the participant's blood when fasting | Measurement of the amount of C-peptide in the participant's blood when fasting | Fasting C-peptide value | Numeric Values |
Measured in ng/mL (U.S.) or nmol/L (outside U.S.) |
Adult;Pediatric | Supplemental | 2.00 | 2024-02-29 15:53:40.0 | Diabetes Labs | Laboratory Tests and Biospecimens/Biomarkers | Assessments and Examinations |
Free-Form Entry |
nanogram per milliliter | ||||||||||
C19728 | Laboratory procedure VLDL cholesterol measurement | LabProcedVLDLCholesterolMeasr | Measurement of the amount of very low density lipoprotein (VLDL) cholesterol in the participant's blood | Measurement of the amount of very low density lipoprotein (VLDL) cholesterol in the participant's blood | Cholesterol - VLDL value | Numeric Values |
Measured in mg/dL (U.S.) or mmol/L (outside U.S.) |
Adult;Pediatric | Supplemental | 2.00 | 2024-02-29 15:53:44.0 | Diabetes Labs | Laboratory Tests and Biospecimens/Biomarkers | Assessments and Examinations |
Free-Form Entry |
milligram per deciliter | ||||||||||
C18146 | Laboratory procedure HDL cholesterol measurement | LabProcedHDLCholesterolMeasr | Measurement of the amount of high density lipoprotein (HDL) cholesterol in the participant's blood | Measurement of the amount of high density lipoprotein (HDL) cholesterol in the participant's blood | Cholesterol - HDL value | Numeric Values |
Measured in mg/dL (U.S.) or mmol/L (outside U.S.) |
Adult;Pediatric | Supplemental | 4.00 | 2024-02-29 15:53:42.0 | Diabetes Labs | Laboratory Tests and Biospecimens/Biomarkers | Assessments and Examinations |
Free-Form Entry |
0 | 500 | milligram per deciliter | ||||||||
C19729 | Laboratory procedure vitamin D twenty five hydroxy measurement | LabProcedVitaminD25HydrxyMeasr | Measurement of the amount of vitamin D twenty five hydroxy in the participant's blood | Measurement of the amount of vitamin D twenty five hydroxy in the participant's blood | Vitamin D, 25-hydroxy value | Numeric Values |
Measured in ng/mL (U.S.) or nmol/L (outside U.S.) |
Adult;Pediatric | Exploratory | 2.00 | 2024-02-29 15:53:46.0 | Diabetes Labs | Laboratory Tests and Biospecimens/Biomarkers | Assessments and Examinations |
Free-Form Entry |
nanogram per milliliter | ||||||||||
C18147 | Laboratory procedure LDL cholesterol measurement | LabProcedLDLCholesterolMeasr | Measurement of the amount of low density lipoprotein (LDL) cholesterol in the participant's blood | Measurement of the amount of low density lipoprotein (LDL) cholesterol in the participant's blood | Cholesterol - LDL value | Numeric Values |
Measured in mg/dL (U.S.) or mmol/L (outside U.S.) |
Adult;Pediatric | Supplemental | 4.00 | 2024-02-29 15:53:42.0 | Diabetes Labs | Laboratory Tests and Biospecimens/Biomarkers | Assessments and Examinations |
Free-Form Entry |
0 | 500 | milligram per deciliter |